Erhardt, A., L. Czibere, D. Roeske, S. Lucae, P. G. Unschuld, S. Ripke, M. Specht, M. A. Kohli, S. Kloiber, M. Ising, A. Heck, H. Pfister, P. Zimmermann, R. Lieb, B. Pütz, M. Uhr, P. Weber, J. M. Deussing, M. Gonik, M. Bunck, M. S. Kessler, E. Frank, C. Hohoff, K. Domschke, P. Krakowitzky, W. Maier, B. Bandelow, C. Jacob, J. Deckert, S. Schreiber, J. Strohmaier, M. Nöthen, S. Cichon, M. Rietschel, T. Bettecken, M. E. Keck, R. Landgraf, B. Müller-Myhsok, F. Holsboer and E. B. Binder: TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. In: Molecular Psychiatry 16, 6, 647-663 (2011).
Hohoff, C., E. L. Mullings, S. V. Heatherley, C. M. Freitag, L. C. Neumann, K. Domschke, P. Krakowitzky, M. Rothermundt, M. E. Keck, A. Erhardt, P. G. Unschuld, C. Jacob, J. Fritze, B. Bandelow, W. Maier, F. Holsboer, P. J. Rogers and J. Deckert: Adenosine A(2A) receptor gene: Evidence for association of risk variants with panic disorder and anxious personality. In: Journal of Psychiatric Research 44, 14, 930-937 (2010).
Kloiber, S., M. A. Kohli, T. Brueckl, S. Ripke, M. Ising, M. Uhr, A. Menke, P. G. Unschuld, S. Horstmann, D. Salyakina, B. Müller-Myhsok, E. B. Binder, F. Holsboer and S. Lucae: Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. In: Molecular Psychiatry 15, 7, 736-747 (2010).
Unschuld, P. G., M. Ising, D. Roeske, A. Erhardt, M. Specht, S. Kloiber, M. Uhr, B. Müller-Myhsok, F. Holsboer and E. B. Binder: Gender-Specific Association of Galanin Polymorphisms with HPA-Axis Dysregulation, Symptom Severity, and Antidepressant Treatment Response. In: Neuropsychopharmacology 35, 7, 1583-1592 (2010).
Unschuld, P. G., M. Ising, M. Specht, A. Erhardt, S. Ripke, A. Heck, S. Kloiber, V. Straub, T. Brueckl, B. Müller-Myhsok, F. Holsboer and E. B. Binder: Polymorphisms in the GAD2 Gene-Region Are Associated With Susceptibility for Unipolar Depression and With a Risk Factor for Anxiety Disorders. In: American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 150B, 8, 1100-1109 (2009).
Kloiber, S., M. A. Kohli, T. Brückl, S. Ripke, M. Ising, M. Uhr, A. Menke, P. G. Unschuld, S. Horstmann, D. Salyakina, B. Müller-Myhsok, E. B. Binder, F. Holsboer and S. Lucae: Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. In: Pharmacopsychiatry 42, 5, 226-226 (2009).
Unschuld, P. G., M. Ising, D. Roeske, A. Erhardt, M. Specht, S. Ripke, M. Uhr, S. Kloiber, B. Müller-Myhsok, F. Holsboer and E. B. Binder: Polymorphisms in the gene encoding the neuropeptide galanin are associated with HPA-axis dysregulation and symptome severity in major-depressive- and anxiety-disorder patients. In: Pharmacopsychiatry 42, 5, 244-244 (2009).
Thoeringer, C. K., S. Ripke, P. G. Unschuld, S. Lucae, M. Ising, T. Bettecken, M. Uhr, M. E. Keck, B. Mueller-Myhsok, F. Holsboer, E. B. Binder and A. Erhardt: The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. In: Journal of Neural Transmission 116, 6, 649-657 (2009).
Keck, M. E., N. Kern, A. Erhardt, P. G. Unschuld, M. Ising, D. Salyakina, M. B. Müller, C. C. Knorr, R. Lieb, C. Hohoff, P. Krakowitzky, W. Maier, B. Bandelow, J. Fritze, J. Deckert, F. Holsboer, B. Müller-Myhsok and E. B. Binder: Combined Effects of Exonic Polymorphisms in CRHR1 and AVPR1B Genes in a Case/Control Study for Panic Disorder. In: American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 147B, 7, 1196-1204 (2008).
Erhardt, A., S. Lucae, N. Kern, P. G. Unschuld, M. Ising, R. Lieb, M. Uhr, C. Hohoff, J. Deckert, B. Bandelow, W. Maier, E. B. Binder, B. Müller-Myhsok, M. E. Keck and F. Holsboer: Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks. In: Molecular Psychiatry 13, 3, 242-243 (2008).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.